These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30830168)

  • 1. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology.
    Libby P; Kobold S
    Cardiovasc Res; 2019 Apr; 115(5):824-829. PubMed ID: 30830168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease.
    Aboumsallem JP; Moslehi J; de Boer RA
    J Am Heart Assoc; 2020 Jan; 9(2):e013754. PubMed ID: 31960736
    [No Abstract]   [Full Text] [Related]  

  • 3. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of imperatorin in the cardiovascular system and cancer.
    Nasser MI; Zhu S; Hu H; Huang H; Guo M; Zhu P
    Biomed Pharmacother; 2019 Dec; 120():109401. PubMed ID: 31622950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases.
    Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F
    Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    de Boer RA; Hulot JS; Tocchetti CG; Aboumsallem JP; Ameri P; Anker SD; Bauersachs J; Bertero E; Coats AJS; Čelutkienė J; Chioncel O; Dodion P; Eschenhagen T; Farmakis D; Bayes-Genis A; Jäger D; Jankowska EA; Kitsis RN; Konety SH; Larkin J; Lehmann L; Lenihan DJ; Maack C; Moslehi JJ; Müller OJ; Nowak-Sliwinska P; Piepoli MF; Ponikowski P; Pudil R; Rainer PP; Ruschitzka F; Sawyer D; Seferovic PM; Suter T; Thum T; van der Meer P; Van Laake LW; von Haehling S; Heymans S; Lyon AR; Backs J
    Eur J Heart Fail; 2020 Dec; 22(12):2272-2289. PubMed ID: 33094495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension management in cardio-oncology.
    Essa H; Dobson R; Wright D; Lip GYH
    J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical approach to the inflammatory etiology of cardiovascular diseases.
    Ruscica M; Corsini A; Ferri N; Banach M; Sirtori CR
    Pharmacol Res; 2020 Sep; 159():104916. PubMed ID: 32445957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-oncology: where do we stand for in Belgium?
    Lancellotti P; De Pauw M; Claeys M
    Acta Cardiol; 2021 Apr; 76(2):204-208. PubMed ID: 31967938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and CVD in 2017: From clonal haematopoiesis to the CANTOS trial.
    Swirski FK
    Nat Rev Cardiol; 2018 Feb; 15(2):79-80. PubMed ID: 29263444
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week.
    Hayek SS; Ganatra S; Lenneman C; Scherrer-Crosbie M; Leja M; Lenihan DJ; Yang E; Ryan TD; Liu J; Carver J; Mousavi N; O'Quinn R; Arnold A; Banchs J; Barac A; Ky B
    J Am Coll Cardiol; 2019 May; 73(17):2226-2235. PubMed ID: 31047011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-Oncology for the Primary Care Provider.
    Jhawar N; Mcpherson A; Chirila R; Ray J
    Rom J Intern Med; 2023 Sep; 61(3):127-134. PubMed ID: 37249550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional strategies to manage heart failure in patients with cancer.
    Porter C; Slosky D
    Heart Fail Clin; 2011 Jul; 7(3):395-402. PubMed ID: 21749891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
    Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
    Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.